
Deals
SRX Global Agrees to Buy Cell Therapy Developer CERo Therapeutics
A special purpose vehicle, CERO 1236, will raise money directly into the subsidiary so existing SRX shareholders are not diluted, the company said.
Bootstrapped Wealth reported on CERO 1236 on October 7, 2026.
October 7, 2026
The buyer is working with CERO 1236, a special purpose vehicle it wholly owns, according to a statement distributed by GlobeNewswire.

Deals
A special purpose vehicle, CERO 1236, will raise money directly into the subsidiary so existing SRX shareholders are not diluted, the company said.